SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-18-356313
Filing Date
2018-12-21
Accepted
2018-12-21 16:03:09
Documents
3
Group Members
AVALON VENTURES X GP LLCAVALON VENTURES X SPV GP LLCAVALON X SPV I, L.P.BRADEN BOHMANNJAY LICHTER, PH.D.KEVIN KINSELLARICHARD LEVANDOVSTEPHEN TOMLINTIGHE REARDON

Document Format Files

Seq Description Document Type Size
1 SC 13D d660728dsc13d.htm SC 13D 212721
2 EX-99.B d660728dex99b.htm EX-99.B 32859
3 EX-99.C d660728dex99c.htm EX-99.C 9403
  Complete submission text file 0001193125-18-356313.txt   256747
Mailing Address 1134 KLINE STREET LA JOLLA CA 92037
Business Address 1134 KLINE STREET LA JOLLA CA 92037 858-348-2180
Avalon Ventures X, L.P. (Filed by) CIK: 0001557058 (see all company filings)

IRS No.: 460599668 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037 858-750-4715
Synthorx, Inc. (Subject) CIK: 0001609727 (see all company filings)

IRS No.: 464709185 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90741 | Film No.: 181249516
SIC: 2834 Pharmaceutical Preparations